Reviv3 Procare Co. (RVIV)
OTHER OTC:RVIV
US Market

Reviv3 Procare Co (RVIV) Stock Price & Analysis

4 Followers

RVIV Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.20 - $0.70
Previous Close$0.3
Volume176.40K
Average Volume (3M)22.43K
Market Cap
$35.11M
Enterprise Value$30.29M
Total Cash (Recent Filing)$5.06M
Total Debt (Recent Filing)$242.54K
Price to Earnings (P/E)61.0
Beta0.26
Jan 09, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding117,076,949
10 Day Avg. Volume22,484
30 Day Avg. Volume22,426
Standard Deviation0.40
R-Squared0.02
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)10.75
Price to Sales (P/S)5.75
Price to Cash Flow (P/CF)18.50
P/FCF Ratio31.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.19
Enterprise Value/Gross Profit1.71
Enterprise Value/Ebitda14.27
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0


Financials

Annual

RVIV FAQ

What was Reviv3 Procare Co.’s price range in the past 12 months?
Reviv3 Procare Co. lowest stock price was $0.20 and its highest was $0.70 in the past 12 months.
    What is Reviv3 Procare Co.’s market cap?
    Currently, no data Available
    When is Reviv3 Procare Co.’s upcoming earnings report date?
    Reviv3 Procare Co.’s upcoming earnings report date is Jan 09, 2024 which is in 82 days.
      How were Reviv3 Procare Co.’s earnings last quarter?
      Reviv3 Procare Co. released its earnings results on Oct 13, 2023. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
        Is Reviv3 Procare Co. overvalued?
        According to Wall Street analysts Reviv3 Procare Co.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Reviv3 Procare Co. pay dividends?
          Reviv3 Procare Co. does not currently pay dividends.
          What is Reviv3 Procare Co.’s EPS estimate?
          Reviv3 Procare Co.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Reviv3 Procare Co. have?
          Reviv3 Procare Co. has 117,076,950 shares outstanding.
            What happened to Reviv3 Procare Co.’s price movement after its last earnings report?
            Reviv3 Procare Co. reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went up 2.703%.
              Which hedge fund is a major shareholder of Reviv3 Procare Co.?
              Currently, no hedge funds are holding shares in RVIV

              ---

              Reviv3 Procare Co Stock Smart Score

              This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
              Learn more about TipRanks Smart Score

              Company Description

              Reviv3 Procare Co.

              REVIV3 ProCare Co. engages in the manufacture, market, sale and distribution of professional quality hair and skin products. Its products are sold under various trademarks and brands, and has adopted and used the trademark products for distribution throughout the United States, Canada, Europe, and Asia. The company was founded on May 21, 2015 and is headquartered in El Monte, CA.

              ---

              Forecast EPS vs Actual EPS


              Similar Stocks
              Company
              Price & Change
              Follow
              Onconova Therapeutics
              GlycoMimetics
              Viveve Medical
              OpGen

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis